Bath & Body Works (NYSE:BBWI) Given “Outperform” Rating at Telsey Advisory Group

Telsey Advisory Group restated their outperform rating on shares of Bath & Body Works (NYSE:BBWI) in a report issued on Tuesday morning, Benzinga reports. They currently have a $53.00 price objective on the stock. Telsey Advisory Group also issued estimates for Bath & Body Works’ Q2 2025 earnings at $0.36 EPS, Q3 2025 earnings at $0.52 EPS, Q4 2025 earnings at $2.10 EPS, Q1 2026 earnings at $0.43 EPS, Q2 2026 earnings at $0.43 EPS, Q3 2026 earnings at $0.62 EPS and Q4 2026 earnings at $2.31 EPS.

A number of other analysts also recently weighed in on BBWI. Piper Sandler boosted their target price on shares of Bath & Body Works from $44.00 to $45.00 and gave the stock a neutral rating in a report on Tuesday, April 9th. Robert W. Baird upped their price target on shares of Bath & Body Works from $50.00 to $54.00 and gave the company an outperform rating in a report on Friday, March 1st. The Goldman Sachs Group upped their price target on shares of Bath & Body Works from $49.00 to $56.00 and gave the company a buy rating in a report on Monday, March 4th. UBS Group upped their price target on shares of Bath & Body Works from $46.00 to $52.00 and gave the company a neutral rating in a report on Monday, March 4th. Finally, TD Cowen upped their price target on shares of Bath & Body Works from $35.00 to $55.00 and gave the company an outperform rating in a report on Friday, March 1st. Eight research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, Bath & Body Works presently has an average rating of Hold and an average target price of $48.53.

Bath & Body Works Stock Down 0.7 %

Bath & Body Works stock opened at $45.84 on Tuesday. The company’s 50-day moving average price is $47.10 and its 200-day moving average price is $44.06. Bath & Body Works has a twelve month low of $27.30 and a twelve month high of $52.99. The company has a market cap of $10.23 billion, a PE ratio of 11.81, a price-to-earnings-growth ratio of 1.56 and a beta of 1.90.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Tuesday, June 4th. The company reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.33 by $0.05. Bath & Body Works had a net margin of 11.92% and a negative return on equity of 40.00%. The firm had revenue of $1.38 billion for the quarter, compared to the consensus estimate of $1.37 billion. During the same period in the previous year, the firm posted $0.33 EPS. The business’s quarterly revenue was down .9% on a year-over-year basis. As a group, sell-side analysts expect that Bath & Body Works will post 3.27 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 21st. Stockholders of record on Friday, June 7th will be given a $0.20 dividend. The ex-dividend date of this dividend is Friday, June 7th. This represents a $0.80 annualized dividend and a dividend yield of 1.75%. Bath & Body Works’s payout ratio is presently 20.62%.

Insider Transactions at Bath & Body Works

In related news, insider Thomas E. Mazurek sold 4,285 shares of the stock in a transaction that occurred on Wednesday, March 27th. The shares were sold at an average price of $48.89, for a total transaction of $209,493.65. Following the completion of the sale, the insider now owns 45,992 shares of the company’s stock, valued at $2,248,548.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.27% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Westwood Holdings Group Inc. acquired a new stake in shares of Bath & Body Works in the first quarter worth $212,000. DekaBank Deutsche Girozentrale increased its stake in shares of Bath & Body Works by 1.0% in the first quarter. DekaBank Deutsche Girozentrale now owns 31,797 shares of the company’s stock worth $1,560,000 after acquiring an additional 322 shares during the period. Northwest Bank & Trust Co increased its stake in shares of Bath & Body Works by 2.5% in the first quarter. Northwest Bank & Trust Co now owns 13,094 shares of the company’s stock worth $655,000 after acquiring an additional 315 shares during the period. Atria Investments Inc acquired a new stake in shares of Bath & Body Works in the first quarter worth $1,058,000. Finally, Tidal Investments LLC increased its stake in shares of Bath & Body Works by 223.9% in the first quarter. Tidal Investments LLC now owns 19,398 shares of the company’s stock worth $970,000 after acquiring an additional 13,410 shares during the period. Hedge funds and other institutional investors own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.